Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Ketogenic Diet and Potential Micronutrient Risks in Drug-Resistant Epilepsy Management: A Literature Review.

Nutrients·2026
Same author

Family history of type 2 diabetes delays development of type 1 diabetes in TEDDY children with islet autoimmunity.

Diabetologia·2025
Same author

Financial Toxicity Survey in Patients With Gynecologic Cancer.

O&G open·2025
Same author

Serum IL-1ra Is Associated with but Has No Genetic Link to Type 1 Diabetes.

Endocrines·2025
Same author

Transcriptomic Analysis of Human Lens Epithelium Tissue With and Without Cataract Surgery: Uncovering Novel Pathways of Post-Surgical Lens Epithelium Remodeling.

Investigative ophthalmology & visual science·2025
Same author

Elevated Inflammatory Cytokines Persist in the Aqueous Humor Years After Cataract Surgery.

Investigative ophthalmology & visual science·2025

Related Experiment Video

Updated: Jun 27, 2026

Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death
10:34

Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death

Published on: December 21, 2016

Biomarkers for type 1 diabetes.

Sharad Purohit, Jin-Xiong She

    International Journal of Clinical and Experimental Medicine
    |December 17, 2008
    PubMed
    Summary
    This summary is machine-generated.

    Type 1 diabetes (T1D) prediction needs better biomarkers. Combining multiple risk factors and clinical data offers the best approach for accurate T1D risk assessment.

    Keywords:
    Type-1 diabetesbioinformaticsbiomarkersgenomicspredictionproteomics

    More Related Videos

    Electrochemiluminescence Assays for Human Islet Autoantibodies
    09:15

    Electrochemiluminescence Assays for Human Islet Autoantibodies

    Published on: March 23, 2018

    A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
    06:46

    A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

    Published on: July 5, 2022

    Related Experiment Videos

    Last Updated: Jun 27, 2026

    Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death
    10:34

    Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death

    Published on: December 21, 2016

    Electrochemiluminescence Assays for Human Islet Autoantibodies
    09:15

    Electrochemiluminescence Assays for Human Islet Autoantibodies

    Published on: March 23, 2018

    A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
    06:46

    A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

    Published on: July 5, 2022

    Area of Science:

    • Immunology
    • Endocrinology
    • Genetics

    Background:

    • Type 1 diabetes (T1D) is an autoimmune disease targeting insulin-producing beta cells.
    • The autoimmune process begins years before clinical diagnosis, offering a window for intervention.
    • Complex interactions of genes, environment, and the immune system drive T1D autoimmunity.

    Purpose of the Study:

    • To review current understanding of T1D pathogenesis and risk factors.
    • To highlight the need for improved biomarkers for early T1D prediction and prevention.
    • To explore the potential of combining multiple biomarkers for enhanced risk assessment.

    Main Methods:

    • Review of research on T1D susceptibility genes, environmental triggers, and biomarkers.
    • Analysis of demographic and clinical parameters relevant to T1D risk.
    • Evaluation of the predictive power of individual versus combinatorial biomarkers.

    Main Results:

    • Numerous genetic, molecular, cellular, and environmental risk factors have been identified.
    • Individual biomarkers show limited predictive power for T1D.
    • Demographic factors like age and family history are important for risk assessment.

    Conclusions:

    • Current T1D prediction tests are imperfect, necessitating earlier and more accurate biomarkers.
    • Future T1D risk assessment should integrate multiple biomarkers of diverse types.
    • Combining various biomarkers with demographic and clinical information is crucial for successful T1D prediction.